01—Abstract
Summary
Summary of the 8-K filed March 21, 2024. Cited figures are marked; the original filing is the authoritative source.
International Flavors & Fragrances Inc. filed a Form 8-K dated March 21, 2024 under Item 5.02 (Departure of Directors or Certain Officers; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers).
The filing reports that Simon Herriott, who has served as the Company's President, Health & Biosciences since February 2021 and as President, Scent since June 2023, is stepping down from his position as President, Scent, effective April 1, 2024. Mr. Herriott will remain in his position as President, Health & Biosciences. The filing is a narrow leadership change disclosure and does not include any financial results, guidance, or other operating metrics.
The report was signed by Jennifer Johnson, Executive Vice President, General Counsel and Corporate Secretary. For investors, the main takeaway is a change in the leadership of the Scent business effective April 1, 2024, with the executive keeping his other role at the Company.
02—Key points
Key Highlights
- Simon Herriott is stepping down as President, Scent, effective April 1, 2024.
- Herriott will remain as the Company's President, Health & Biosciences.
- Herriott has held the President, Health & Biosciences role since February 2021.
- Herriott has held the President, Scent role since June 2023.
- The change is disclosed under Item 5.02 of Form 8-K, covering departures and appointments of certain officers.
- The filing does not disclose a named successor for the President, Scent role or any compensation terms.
03—Questions
Frequently Asked Questions
What change in leadership did IFF announce?
The Company announced that Simon Herriott is stepping down from his position as President, Scent, effective April 1, 2024.
Is Simon Herriott leaving the Company?
No. The filing states that Mr. Herriott will remain in his position as the Company's President, Health & Biosciences.
How long has Simon Herriott held his roles?
He has served as President, Health & Biosciences since February 2021 and as President, Scent since June 2023.
Does the filing name a replacement for the President, Scent role?
No. The filing does not identify a successor for the President, Scent position.
Why was this filed on Form 8-K?
The filing is made under Item 5.02, which covers departures of directors or certain officers and related appointments or compensatory arrangements.
04—Continue